GlassScriptPhysician profile
Kimber Leigh Guinn
NPI 1962853986
$1,961.36
in general payments reported to CMS, 2019-2025
35 companies · $419 in 2025
The $419 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $42.89 · 2021: $13.61 · 2022: $271 · 2023: $494 · 2024: $573 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $317.65 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $273.22 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $165.99 | 2019-2025 | Shingrix, Arexvy, Pediarix |
| Merck Sharp & Dohme LLC | $122.40 | 2022-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Pfizer INC. | $100.55 | 2023-2025 | |
| Sanofi Pasteur INC. | $98.88 | 2019-2025 | |
| Dexcom, INC. | $90.97 | 2023-2025 | Dexcom G6 Transmitter |
| Sobi, INC | $77.29 | 2022-2023 | |
| Daiichi Sankyo INC. | $54.84 | 2022-2023 | Injectafer |
| Medtronic, INC. | $53.56 | 2024 | Intellis Adaptivestim, Minimed 780g |
| Z-Medica, LLC | $45.43 | 2019 | |
| Neurocrine Biosciences, INC. | $44.79 | 2023-2024 | Ingrezza |
| Abbott Laboratories | $40.98 | 2025 | Freestyle Libre |
| Kyowa Kirin, INC. | $39.55 | 2024 | Crysvita |
| Lilly USA, LLC | $33.22 | 2023-2025 | Jardiance, Baqsimi |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $33.05 | 2025 | |
| Phathom Pharmaceuticals, INC. | $28.78 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $26.60 | 2023-2024 | |
| Amarin Pharma, INC. | $26.27 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $24.47 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.79 | 2019-2023 | Flumist Quadrivalent |
| Xeris Pharmaceuticals, INC. | $20.79 | 2024 | Keveyis |
| Novartis Pharmaceuticals Corporation | $20.56 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $19.83 | 2023 | |
| Alexion Pharmaceuticals, INC. | $18.37 | 2022 | |
| Shield Therapeutics INC | $18.08 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $17.44 | 2024 | Austedo Xr |
| Idorsia Pharmaceuticals US INC | $17.36 | 2023 | Quviviq |
| Neurelis, INC. | $17.24 | 2024 | Valtoco |
| Ironshore Pharmaceuticals INC. | $16.86 | 2023 | Jornay Pm |
| Ethicon US, LLC | $16.12 | 2022 | |
| Sumitomo Pharma America, INC. | $16.05 | 2024 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.71 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.62 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimber Guinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.